These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 15681052

  • 21. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
    Bartusel T, Schubert S, Klempnauer KH.
    Gene; 2005 May 23; 351():171-80. PubMed ID: 15922873
    [Abstract] [Full Text] [Related]

  • 22. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.
    Oh JM, Kim SH, Lee YI, Seo M, Kim SY, Song YS, Kim WH, Juhnn YS.
    Carcinogenesis; 2009 Jan 23; 30(1):141-9. PubMed ID: 18849297
    [Abstract] [Full Text] [Related]

  • 23. Expression of the Op18 gene is maintained by the CCAAT-binding transcription factor NF-Y.
    Benlhabib H, Herrera JE.
    Gene; 2006 Aug 01; 377():177-85. PubMed ID: 16757134
    [Abstract] [Full Text] [Related]

  • 24. The bidirectional promoter of two genes for the mitochondrial translational apparatus in mouse is regulated by an array of CCAAT boxes interacting with the transcription factor NF-Y.
    Zanotto E, Shah ZH, Jacobs HT.
    Nucleic Acids Res; 2007 Aug 01; 35(2):664-77. PubMed ID: 17179180
    [Abstract] [Full Text] [Related]

  • 25. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J.
    Cancer Res; 2006 Mar 01; 66(5):2544-52. PubMed ID: 16510571
    [Abstract] [Full Text] [Related]

  • 26. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J, Martínez-Gac L, Calonge E, Rodríguez-Martínez M, Molina-Privado I, Redondo JM, Alcamí J, Flemington EK, Campanero MR.
    Carcinogenesis; 2009 Mar 01; 30(3):440-8. PubMed ID: 19126644
    [Abstract] [Full Text] [Related]

  • 27. Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter.
    Boggs K, Reisman D.
    Oncogene; 2006 Jan 26; 25(4):555-65. PubMed ID: 16158047
    [Abstract] [Full Text] [Related]

  • 28. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA, Lee JM.
    FEBS Lett; 2005 Feb 14; 579(5):1001-7. PubMed ID: 15710382
    [Abstract] [Full Text] [Related]

  • 29. The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface.
    Marchetti B, Ashrafi GH, Tsirimonaki E, O'Brien PM, Campo MS.
    Oncogene; 2002 Nov 07; 21(51):7808-16. PubMed ID: 12420217
    [Abstract] [Full Text] [Related]

  • 30. NF-Y-dependent cyclin B2 expression in colorectal adenocarcinoma.
    Park SH, Yu GR, Kim WH, Moon WS, Kim JH, Kim DG.
    Clin Cancer Res; 2007 Feb 01; 13(3):858-67. PubMed ID: 17289878
    [Abstract] [Full Text] [Related]

  • 31. Synergistic effect of cyclic AMP and insulin on the expression of cyclin A gene in Swiss 3T3 cells.
    Lee YH, Park JS, Park CH, Lee SK.
    Biochem Biophys Res Commun; 1998 Mar 27; 244(3):843-8. PubMed ID: 9535754
    [Abstract] [Full Text] [Related]

  • 32. Transactivation of murine cyclin A by polyomavirus large and small T antigens.
    Schüchner S, Nemethova M, Belisova A, Klucky B, Holnthoner W, Wintersberger E.
    J Virol; 2001 Jul 27; 75(14):6498-507. PubMed ID: 11413317
    [Abstract] [Full Text] [Related]

  • 33. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT, Reynolds JG, Gilmore TD.
    Oncogene; 2005 Nov 10; 24(49):7355-68. PubMed ID: 16027730
    [Abstract] [Full Text] [Related]

  • 34. Characterization of the human EDF-1 minimal promoter: involvement of NFY and Sp1 in the regulation of basal transcription.
    Bolognese F, Pitarque-Martì M, Lo Cicero V, Mantovani R, Maier JA.
    Gene; 2006 Jun 07; 374():87-95. PubMed ID: 16567061
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the promoter of the gene encoding human tripeptidyl-peptidase II and identification of upstream silencer elements.
    Lindås AC, Tomkinson B.
    Gene; 2007 May 15; 393(1-2):62-9. PubMed ID: 17343995
    [Abstract] [Full Text] [Related]

  • 36. The biochemical and biological functions of human papillomavirus type 16 E5 protein.
    Tsai TC, Chen SL.
    Arch Virol; 2003 Aug 15; 148(8):1445-53. PubMed ID: 12898324
    [Abstract] [Full Text] [Related]

  • 37. Modulation of cell function by small transmembrane proteins modeled on the bovine papillomavirus E5 protein.
    Freeman-Cook LL, Dimaio D.
    Oncogene; 2005 Nov 21; 24(52):7756-62. PubMed ID: 16299535
    [Abstract] [Full Text] [Related]

  • 38. Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours.
    Borzacchiello G, Russo V, Gentile F, Roperto F, Venuti A, Nitsch L, Campo MS, Roperto S.
    Oncogene; 2006 Feb 23; 25(8):1251-60. PubMed ID: 16205631
    [Abstract] [Full Text] [Related]

  • 39. The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I.
    Araibi EH, Marchetti B, Dornan ES, Ashrafi GH, Dobromylskyj M, Ellis SA, Campo MS.
    Virology; 2006 Sep 15; 353(1):174-83. PubMed ID: 16806386
    [Abstract] [Full Text] [Related]

  • 40. Bovine papillomavirus oncoprotein E5 induces the NF kappa B activation through superoxide radicals.
    Kilk A, Talpsepp T, Väli U, Ustav M.
    Biochem Mol Biol Int; 1996 Nov 15; 40(4):689-97. PubMed ID: 8950027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.